China Universal Asset Management Company’s Neumora Therapeutics NMRA Stock Holding History

China Universal Asset Management Company’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.1K	Sell	29,488 -163	-0.5%	-$310	﹤0.01%	462
2026 Q1	$57.8K	Buy	29,651 +2,424	+9%	+$6.28K	﹤0.01%	449
2025 Q4	$48.7K	Sell	27,227 -1,160	-4%	-$2.54K	﹤0.01%	456
2025 Q3	$51.7K	Sell	28,387 -4,099	-13%	-$6.63K	﹤0.01%	431
2025 Q2	$23.8K	Buy	32,486 +80	+0.2%	+$61	﹤0.01%	448
2025 Q1	$32.4K	Sell	32,406 -1,851	-5%	-$3.17K	﹤0.01%	442
2024 Q4	$363K	Buy	+34,257	New	+$411K	0.03%	279

Other funds holding NMRA

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Addis & Hill Wayne, Pennsylvania $181M AUM 21.74% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LPT

Legacy Private Trust Neenah, Wisconsin $1.81B AUM 19.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

China Universal Asset Management Company's NMRA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Neumora Therapeutics (NMRA) stake by 0.55% in Q2 2026, selling an estimated $310 and leaving 29,488 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #462.

China Universal Asset Management Company first reported a position in NMRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $363K in Q4 2024. 11 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

China Universal Asset Management Company held 29,488 shares of Neumora Therapeutics worth $50.1K as of Q2 2026.
China Universal Asset Management Company sold 163 Neumora Therapeutics shares in Q2 2026, an estimated $310.
Neumora Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #462 holding.
China Universal Asset Management Company first reported a position in Neumora Therapeutics in Q4 2024 and has held it in 7 quarters since.
China Universal Asset Management Company's Neumora Therapeutics position peaked at $363K in Q4 2024.
11 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.